Strelkov Ileana S, Davie James R
Manitoba Institute of Cell Biology, Winnipeg, Manitoba, R3E 0V9 Canada.
Cancer Res. 2002 Jan 1;62(1):75-8.
Stimulation of the Ras-mitogen-activated protein kinase (MAPK) pathway by growth factors, phorbol esters, and oncoproteins results in the phosphorylation of histone H3. Rsk-2 and MSK1 have been reported to be H3 kinases activated by the Ras-MAPK signal transduction pathway. In this study, we used inhibitors of Rsk-2 and MSK1 to decide which of these kinases was responsible for the 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced phosphorylation of H3 in 10T(1/2) and Ciras-3 (H-ras-transformed 10T(1/2)) mouse fibroblasts. These studies demonstrated that MSK1, but not Rsk-2, was the H3 kinase activated in these cells. Furthermore, assays with Rsk-2 showed that this kinase phosphorylates H2B but not H3 in vitro. H89, a potent MSK1 inhibitor, prevented TPA induction of H3 phosphorylation and diminished the TPA-induced expression of the c-fos and urokinase plasminogen activator genes. We propose that persistent activation of the Ras-MAPK pathway and MSK1 resulting in the elevation of phosphorylated H3 levels may contribute to the aberrant gene expression observed in the oncogene-transformed cells.
生长因子、佛波酯和癌蛋白对Ras-丝裂原活化蛋白激酶(MAPK)途径的刺激会导致组蛋白H3磷酸化。据报道,Rsk-2和MSK1是由Ras-MAPK信号转导途径激活的H3激酶。在本研究中,我们使用Rsk-2和MSK1的抑制剂来确定这些激酶中哪一种负责12-O-十四烷酰佛波醇-13-乙酸酯(TPA)诱导的10T(1/2)和Ciras-3(H-ras转化的10T(1/2))小鼠成纤维细胞中H3的磷酸化。这些研究表明,在这些细胞中被激活的H3激酶是MSK1,而非Rsk-2。此外,对Rsk-2的检测表明,该激酶在体外使H2B而非H3磷酸化。强效MSK1抑制剂H89可阻止TPA诱导的H3磷酸化,并减少TPA诱导的c-fos和尿激酶型纤溶酶原激活剂基因的表达。我们提出,Ras-MAPK途径和MSK1的持续激活导致磷酸化H3水平升高,这可能与癌基因转化细胞中观察到的异常基因表达有关。